• Evotec, Novo Nordisk Enter Strategic Diabetes Alliance contractpharma
    August 23, 2018
    Evotec AG has entered a strategic alliance with Novo Nordisk to discover and develop novel small molecule therapies to treat diabetes and obesity, as well as co-morbidities such as nonalcoholic steatohepatitis (NASH), cardiovascular diseases, and diabetic
PharmaSources Customer Service